Reversal of the Polypharmacy-Survival Relationship in Poor Prognosis Cancer Patients
As seen at the CRUK Data Conference ’24 Estimation of prognosis is vital for informing decisions around care and its value, especially in patients with poor prognosis cancer (PPC) where there is a risk of under- or over-treatment. Established risk stratification tools can be derived from routine healthcare records, allowing population-level research. A well-used example […]